MIRA INFORM REPORT

 

 

Report Date :

10.10.2007

 

IDENTIFICATION DETAILS

 

Name :

KORTEN PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

1 A, Ojha Niwas, Patel Estate Marg, Jogeshwari (West), Mumbai – 400 102, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

05.11.1990

 

 

Com. Reg. No.:

11-58797

 

 

CIN No.:

[Company Identification No.]

U24239MH1990PTC058797

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMK04733B

 

 

PAN No.:

[Permanent Account No.]

AAACK5781D

 

 

Legal Form :

Private Limited Liability Company.

 

 

Line of Business :

Manufacture, import, export, buy, sell, distribute and deal in pharmaceutical products, bulk drugs & chemicals, human, animal and plant health care also specialities, patent & proprietory medicines containing these products.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 210000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having satisfactory track. Directors are reported as experience and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

1 A, Ojha Niwas, Patel Estate Marg, Jogeshwari (West), Mumbai – 400 102, Maharashtra, INDIA.

Tel. No.:

91- 22- 26783546 / 26796093

Fax No.:

91- 22- 26785983

E-Mail :

korten@vsnl.com

arunw@vsnl.com

 

 

Factory 1 :

Plot Numbers 1 to 5, Shantisthan, Village Shirgaon, Taluka Palghar, District Thane – 401 407, Maharashtra, India

Tel. No.:

91- 0252-2554560

Area :

5666.5 Sq. Mtrs.

 

 

DIRECTORS

 

Name :

Mr. Kirti S. Sheth

Designation :

Chairman cum Managing Director

Address :

1 A, Ojha Niwas, Patel Estate Marg, Jogeshwari (West), Mumbai – 400 102, Maharashtra, India

kirtisheth@mtnl.net.in

Date of Birth/Age :

04.09.1934

Date of Appointment :

05.11.1990

 

 

Name :

Mr. Shirish N. Daftary

Designation :

Director

Address :

2, Ashoknagar Society, North South Road, JVPD scheme, Mumbai – 400 049, Maharashtra, India.

Date of Birth/Age :

30.11.1933

Date of Appointment :

30.09.1996

 

 

Name :

Mr. Ashok D. Mahajan

Designation :

Director

Address :

Steam Limited, 1st Floor, Nirman, appointed as Director by AGM nominated by Steam.

Date of Birth/Age :

04.07.1956

Date of Appointment :

11.06.2002

 

 

Name :

Mr. Laxman N. Godbole

Designation :

Director

Address :

A – 41, Sukhada Society, Pandurangwadi, Road Number 4, Goregaon (East), Mumbai – 400 063, Maharashtra, India

tatami@vsnl.com

Date of Birth/Age :

07.03.1937

Date of Appointment :

05.11.1990

 

 

Name :

Mr. Madhav Laxman Deshpande

Designation :

Director

Address :

404, 5-C, Alica Nagar, Lokhandwala Complex, Akruli Road, Kandivali East, Mumbai – 400101, Maharashtra, India

mldeshpande@thermolabindia.com

Date of Birth/Age :

05.06.1932

Date of Appointment :

03.04.2006

 

 

Name :

Ms. Neelam Sandip Mahtre

Designation :

Director

Address :

201-B Sukhshanti Mandir Chsl, Pappdy Village, Vasai West, Thane – 401202, Maharashtra, India

Date of Birth/Age :

01.10.1965

Date of Appointment :

03.04.2006

 

 

Name :

Mr. Sandip Pramod Mhatre

Designation :

Director

Address :

201-B Sukhshanti Mandir Chsl, Pappdy Village, Vasai West, Thane – 401202, Maharashtra, India

sandipmhatre@thermolabindia.com

Date of Birth/Age :

04.11.1967

Date of Appointment :

03.04.2006

 

 

KEY EXECUTIVES

 

Name :

Mr. Laxman N. Godbole

Designation :

Secretary

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Kirti S. Sheth

 

216000

Laxman N. Godbole

 

12000

Sindhu S. Daftary

 

27000

Gaurang S. Daftary

 

5000

Amit S. Daftary

 

5000

Shirish N. Daftary

 

4000

Mansuklal V. Shah

 

1500

Chandrika M. Shah

 

2500

Shirish N. Daftary

 

27000

Total

 

300000

 

 

 

Equity Share Breakup

 

 

Category

 

Percentage of Holding

Bodies corporate

 

60.00

Directors or relatives of directors

 

40.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacture, import, export, buy, sell, distribute and deal in pharmaceutical products, bulk drugs & chemicals, human, animal and plant health care also specialities, patent & proprietory medicines containing these products.

 

 

Products :

Product Description

ITC Code No

Diclofenac Sodium Inj

3003.10

Methylergometrine Malete Inj

3003.10

Xylometazoline Hcl Drops

3003.10

 

 

GENERAL INFORMATION

 

Suppliers :

·         Adit Containers Private Limited

·         Krishna Manufacturers Private Limited

·         Kapoor Glass (India) Private Limited

·         Supreme Vinyal Claims Limited

·         Bhansali Packwell

·         Emess Plastics Works

 

 

No. of Employees :

250

 

 

Bankers :

  • Jankalyan Sahakari Bank Limited

140, Vivek Darshan, Sindhi Society, Chembur, Mumbai – 71, Maharashtra

 

  • Hongkong bank
  • SICOM Limited, Mumbai  - 21, Maharashtra
  • HSBC Limited , Fort, Mumbai, Maharashtra

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

B.D. Jokhakar & Company

Chartered Accountants

Address :

8, Ambala Doshi Marg, Fort, Mumbai, Maharashtra

Tel. No.:

91-22-22654882 / 2651731

Fax No.:

91-22-2657093

E-Mail :

bdj@bom3.vsnl.net.in

 

 

Associates/Subsidiaries :

Nil

 


 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

300000

Equity Shares

Rs. 100/- each

Rs.30.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

300000

Equity Shares

Rs. 100/- each

Rs.30.000 millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

30.000

30.000

2] Reserves & Surplus

 

22.519

19.801

NETWORTH

 

52.519

49.801

LOAN FUNDS

 

 

 

1] Secured Loans

 

36.333

25.312

2] Unsecured Loans

 

44.036

53.136

TOTAL BORROWING

 

80.369

78.448

DEFERRED TAX LIABILITIES

 

13.133

15.031

 

 

 

 

TOTAL

 

146.021

143.280

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

142.313

129.532

Capital work-in-progress

 

0.000

8.211

 

 

 

 

INVESTMENT

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

22.136

22.240

 

Sundry Debtors

 

13.801

5.851

 

Cash & Bank Balances

 

1.811

0.963

 

Loans & Advances

 

15.014

11.602

Total Current Assets

 

52.762

40.656

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

34.911

21.811

 

Provisions

 

14.143

13.308

Total Current Liabilities

 

49.054

35.119

Net Current Assets

 

3.708

5.537

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

146.021

143.280

 


KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2006

31.03.2005

Debt Equity Ratio

(Total Liability/Networth)

 

 

2.46

2.28

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.08

1.16

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Fixed Assets

 

  • Freehold Land
  • Factory Building
  • Residence Premises
  • Plant & Machinery
  • Office & Equipment
  • Furniture & Fixture
  • Vehicles

 

 

Corporate identity number of the company

U24239MH1990PTC058797

Name of the company

KORTEN PHARMACEUTICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

1 A, Ojha Niwas, Patel Niwas Marg, Jogeshwari [West], Mumbai – 400102, Maharashtra, India

This form is for

Modification of Charge

Type of charge

Equitable mortgage or mortgage of property by deposition the title deeds

Particular of charge holder

Bank of India

Malad [West] Branch, S V Road, Malad [West], Mumbai – 400064, Maharashtra, India

maladw@bankofindia.co.in

Amount secured by the charge

Rs. 10.000 Millions

Charge identification number of the charge to be modified

90153977

Brief description of the instrument modifying the charge under section 135

Record of Extension of Equitable Mortgage

Date of instrument modifying the charge

17.04.2006

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.39.31

UK Pound

1

Rs.80.12

Euro

1

Rs.55.76

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions